KAPLAN GILLA 4
4 · Avalo Therapeutics, Inc. · Filed Oct 3, 2022
Insider Transaction Report
Form 4
KAPLAN GILLA
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-30+3,080→ 3,080 totalExercise: $3.32From: 2022-09-30Exp: 2032-09-30→ Common Stock (3,080 underlying)
Footnotes (1)
- [F1]100% of the stock option will immediately vest on the date that it is granted.